SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Long-Term Survival of the GeparOLA Study: Neoadjuvant Paclitaxel/Olaparib vs. Paclitaxel/Carboplatinum in Patients With HER2- BC and Homologous Recombination Deficiency
By
SABCS 2022 Conference Coverage
FEATURING
Peter Fasching
By
SABCS 2022 Conference Coverage
FEATURING
Peter Fasching
102 views
January 20, 2023
Comments 0
Login to view comments.
Click here to Login
Videos